What is the new medication for chronic fatigue syndrome? Emerging therapies and clinical trials
•
4 min read
As of late 2025, no single new medication has received broad FDA approval specifically for the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). The field of pharmacology for this complex neuroimmune disease is primarily focused on investigating repurposed drugs, supplements, and targeted therapies to manage symptoms while researchers continue to unravel its underlying causes. This exploration addresses the critical need for effective treatment and highlights a variety of promising approaches in clinical development.
